vix.ing · top · new · best · stats · spec

Evelien Dekker

  1. Polyp Miss Rate Determined by Tandem Colonoscopy: A Systematic Review
    2006/02/01 by Jeroen C. van Rijn, Johannes B. Reitsma, Jaap Stoker +4 · 45 citations
    Medicine · #Adenoma #Cancer #Colonoscopy #Colorectal Cancer Screening and Detection #Colorectal Polyp #Colorectal cancer #Gastric Cancer Management and Outcomes #Gastroenterology #Gold standard (test) #Internal medicine #Medicine #Microscopic Colitis #Polypectomy
  2. Novel classification for adverse events in GI endoscopy: the AGREE classification
    2021/12/08 by Karlijn J. Nass, Liselotte W. Zwager, Manon van der Vlugt +7 · 26 citations
    Immunology and Microbiology · Medicine · #Adverse effect #Colorectal Cancer Screening and Detection #Computer science #Endoscopy #Esophageal and GI Pathology #Grading (engineering) #Internal medicine #Medical Device Sterilization and Disinfection #Medical physics #Medicine #Standardization
  3. Endoscopic surveillance after surgical or endoscopic resection for colorectal cancer: European Society of Gastrointestinal Endoscopy (ESGE) and European Society of Digestive Oncology (ESDO) Guideline
    2019/02/05 by Cesare Hassan, Piotr Wysocki, Lorenzo Fuccio +24 · 23 citations
    Medicine · #Cancer #Colonoscopy #Colorectal Cancer Screening and Detection #Colorectal Cancer Surgical Treatments #Colorectal cancer #Endoscopic mucosal resection #Endoscopy #Gastric Cancer Management and Outcomes #General surgery #Guideline #Internal medicine #Medicine #Pathology #Perioperative #Surgery
  4. The proximal serrated polyp detection rate is an easy-to-measure proxy for the detection rate of clinically relevant serrated polyps
    2015/05/02 by Joep IJspeert, Joep E.G. IJspeert, Sascha C. van Doorn +4 · 16 citations
    Medicine · #Cancer #Colonoscopy #Colorectal Cancer Screening and Detection #Colorectal Polyp #Colorectal cancer #Confidence interval #Confounding #Diverticular Disease and Complications #Gastric Cancer Management and Outcomes #Gastroenterology #Internal medicine #Logistic regression #Medicine #Multivariate analysis #Odds ratio #Prospective cohort study
  5. Eflornithine plus Sulindac for Prevention of Progression in Familial Adenomatous Polyposis
    2020/09/09 by Carol A. Burke, Evelien Dekker, Patrick M. Lynch +28 · 1 citation
    Medicine · Biochemistry, Genetics and Molecular Biology · #Genetic factors in colorectal cancer #Inflammatory mediators and NSAID effects #Connective tissue disorders research #Sulindac #Eflornithine #Medicine #Familial adenomatous polyposis #Hazard ratio #Gastroenterology #Chemoprophylaxis #Internal medicine #Adenomatous polyposis coli #Surgery #Colorectal cancer #Confidence interval #Cancer
  6. Efficacy and safety of eflornithine (CPP-1X)/sulindac combination therapy versus each as monotherapy in patients with familial adenomatous polyposis (FAP): design and rationale of a randomized, double-blind, Phase III trial
    2016/08/01 by Carol A. Burke, Evelien Dekker, N. Jewel Samadder +2 · 1 citation
    Biochemistry, Genetics and Molecular Biology · Medicine · #Polyamine Metabolism and Applications #Microbial metabolism and enzyme function #Glycosylation and Glycoproteins Research #Sulindac #Familial adenomatous polyposis #Medicine #Eflornithine #Gastroenterology #Internal medicine #Clinical endpoint #Colorectal cancer #Placebo #Randomized controlled trial #Chemoprophylaxis #Adenomatous polyposis coli #Adverse effect #Cancer #Ornithine decarboxylase #Pathology